Technology

Roche receives FDA clearance on its digital pathology solution for diagnostic use

Published

7 months ago

June 18, 2024

The solution, which includes the VENTANA DP 200 slide scanner, Roche’s digital pathology workflow software and a display, is now cleared to aid in clinical diagnosis, enabling pathologists to diagnose patients using digital images.

Primary diagnosis for digital pathology enhances healthcare efficiency and helps ensure effective and timely patient care, especially in areas where access to pathologists is limited.

This clearance is a foundational step in Roche’s commitment to enable routine clinical diagnosis with its digital pathology solutions.

TUCSON, Ariz., June 18, 2024 /PRNewswire/ — Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that its whole-slide imaging system, the Roche Digital Pathology Dx (VENTANA DP 200), has received 510(k) clearance from the United States Food and Drug Administration (FDA). The system is intended to aid the pathologist in reviewing and interpreting digital images of scanned pathology slides to help diagnose patients.

“Primary diagnosis for digital pathology streamlines the digital workflow that empowers pathologists to make a timely diagnosis from anywhere,” said Jill German, Head of Pathology Lab for Roche Diagnostics. “This not only improves a pathology lab’s efficiency but also expands access to pathologists for people living in remote areas and increases opportunities for pathologists to collaborate on patient cases.”

Digital pathology refers to the digitalisation of the traditional pathology workflow, starting from slide scanning, to visualisation, to analysis. Digital pathology is transforming traditional histopathology by improving efficiency, depth of analysis, and opportunity for collaboration in pathology workflows. For example, once a slide scanner captures and converts stained tissue on glass slides to digital images, these images can be managed, shared, and analysed by pathologists and can help determine a cancer patient’s treatment.

“We are investing in innovative digital pathology solutions to enable the pathology lab’s digital transformation,” German said. “Artificial intelligence-based tools and our Roche Digital Pathology Open Environment are designed to drive greater adoption and promote innovation in this critical field.”

About Roche Digital Pathology
As the leading provider of pathology lab solutions, Roche is delivering an end-to-end digital pathology solution from tissue staining to producing high-quality digital images that can be reliably assessed using automated AI-based image analysis algorithms. We minimise variables that can impact analysis, and it is this end-to-end development that produces the quality results healthcare providers and researchers can depend on. With the acceleration of immunotherapy and the development of more complex assays, Roche is moving these traditionally research-oriented tools into routine clinical practice and is committed to investing in and shaping the future of pathology.

About Roche
Founded in 1896 in Basel, Switzerland, as one of the first industrial manufacturers of branded medicines, Roche has grown into the world’s largest biotechnology company and the global leader in in-vitro diagnostics. The company pursues scientific excellence to discover and develop medicines and diagnostics for improving and saving the lives of people around the world. We are a pioneer in personalised healthcare and want to further transform how healthcare is delivered to have an even greater impact. To provide the best care for each person we partner with many stakeholders and combine our strengths in Diagnostics and Pharma with data insights from the clinical practice.

In recognising our endeavour to pursue a long-term perspective in all we do, Roche has been named one of the most sustainable companies in the pharmaceuticals industry by the Dow Jones Sustainability Indices for the fifteenth consecutive year. This distinction also reflects our efforts to improve access to healthcare together with local partners in every country we work.

Genentech, in the United States, is a wholly owned member of the Roche Group. Roche is the majority shareholder in Chugai Pharmaceutical, Japan.

For more information, please visit www.roche.com.

All trademarks used or mentioned in this release are protected by law.

Roche Media Relations

Jo Lynn Garing, +1 317-363-7286

View original content to download multimedia:https://www.prnewswire.com/news-releases/roche-receives-fda-clearance-on-its-digital-pathology-solution-for-diagnostic-use-302174821.html

SOURCE Roche

Technology

LB Technology Partners with Motorq to Integrate OEM Data Services

Published

32 minutes ago

January 13, 2025

MEMPHIS, Tenn., Jan. 13, 2025 /PRNewswire/ — LB Technology, a leader in fleet management and telematics solutions, is pleased to announce a strategic partnership with Motorq, a leading connected vehicle data platform, to integrate OEM data services into LB Technology’s suite of fleet solutions. This collaboration enhances LB Technology’s ability to provide real-time insights, streamline operations, and offer data-driven decision-making capabilities to its clients using factory-installed OEM telematics hardware from some of the world’s leading automakers, including General Motors, Ford, Toyota, Stellantis, Volkswagen, Volvo, BMW and more.

Integrating Motorq’s cutting-edge OEM data services will enable LB Technology to deliver richer, more accurate vehicle data, including diagnostics, driver behavior analytics, and predictive maintenance insights across many different vehicle manufacturers to deliver actionable insights on one single platform without needing external devices.

“Integrating Motorq’s OEM data services into our platform represents a significant step forward in our mission to deliver smarter, more efficient solutions on one single platform for fleet operators,” said Matt Courts, CTO of LB Technology. “This partnership empowers our customers with the tools and data they need to operate more safely, cost-effectively, and sustainably. We are excited about the possibilities this collaboration brings.”

“We’re thrilled to partner with LB Technology, a company that shares our vision of harnessing data to drive smarter fleet management,” said Matt Naiman, Senior Vice President of Sales at Motorq. “Our OEM data services bring unparalleled accuracy and depth, providing LB Technology’s customers with the insights they need to optimize their operations and achieve their goals.”

The partnership between LB Technology and Motorq is poised to set a new standard in fleet management. It will enable businesses to unlock the full potential of mixed fleet-connected vehicle data while enhancing safety, efficiency, and productivity.

For more information about this partnership and its benefits, please visit www.fleettrack.com.

About LB Technology
LB Technology is a leading provider of fleet management solutions, delivering cutting-edge telematics technology and data-driven insights to businesses worldwide. By leveraging innovative tools and expertise, LB Technology empowers fleet operators to improve safety, efficiency, and sustainability.

About Motorq
Motorq is a leading connected vehicle data platform that helps businesses unlock the power of OEM data to optimize fleet performance and operations. With a focus on accuracy, security, and actionable insights, Motorq is revolutionizing how organizations manage their fleets.

View original content:https://www.prnewswire.com/news-releases/lb-technology-partners-with-motorq-to-integrate-oem-data-services-302349476.html

SOURCE LB Technology, Inc.

Technology

InventHelp Inventor Develops New Set of Audio Accessories (BDH-351)

Published

32 minutes ago

January 13, 2025

PITTSBURGH, Jan. 13, 2025 /PRNewswire/ — “I wanted to create a way to use either earphones or open-air speakers with one accessory,” said an inventor, from Deridder, La., “so I invented the RACHAL – JOHNSON INVENTION. My design increases options when listening to music or other digital content.”

The patent-pending invention provides a new set of accessories for digital music/media consumers. In doing so, it allows for wireless earphone and speaker use. As a result, it increases convenience. It also offers uninterrupted listening, even when charging the earphones. The invention features a versatile design that is easy to use so it is ideal for the general population. Additionally, a prototype is available.

The original design was submitted to the National sales office of InventHelp. It is currently available for licensing or sale to manufacturers or marketers. For more information, write Dept. 23-BDH-351, InventHelp, 100 Beecham Drive, Suite 110, Pittsburgh, PA 15205-9801, or call (412) 288-1300 ext. 1368. Learn more about InventHelp’s Invention Submission Services at http://www.InventHelp.com.

View original content to download multimedia:https://www.prnewswire.com/news-releases/inventhelp-inventor-develops-new-set-of-audio-accessories-bdh-351-302347421.html

SOURCE InventHelp

Technology

Proper Good, Inc. Successfully Secures New Funding to Fuel Growth

Published

32 minutes ago

January 13, 2025

AUSTIN, Texas, Jan. 13, 2025 /PRNewswire/ — Proper Good, Inc., a leader in ready-to-eat meal solutions, announced today that it successfully secured additional funding in the fourth quarter of 2024 to support the expansion of its 19 affordable meal options, which include oats, soups, and pastas. This milestone underscores the company’s ongoing growth and dedication to providing accessible, ready-made meal choices to a broader audience.

Available in thousands of Walmart locations for under $5 each, Proper Good meals are designed to make healthy and convenient eating accessible to all. The funding round was primarily backed by internal investors and board members, with a strategic focus on driving retail growth and introducing Proper Good to new households in 2025.

“We’re absolutely thrilled to have the incredible backing of our investors as we deepen our retail partnerships,” said Christopher Jane, Co-Founder & CEO of Proper Good. “This support empowers us to bring an even wider variety of delicious, easy meals to Walmart shelves in 2025—making mealtime a breeze for everyone!”

These funds will be strategically deployed to accelerate product development, expand operations, and enhance customer offerings, ensuring Proper Good continues to innovate and lead in the ready-to-eat food space

With a proven track record, innovative solutions, and visionary leadership, Proper Good has garnered significant interest from the investment community. The company remains dedicated to making wholesome, affordable, and convenient meals a staple for households across the nation.

For more information about Proper Good, Inc or to inquire about this offering, please contact:

Media Contact
Jenelle Hamilton PR
Jenelle Hamilton
388645@email4pr.com
+1 646.421.9139

View original content to download multimedia:https://www.prnewswire.com/news-releases/proper-good-inc-successfully-secures-new-funding-to-fuel-growth-302349494.html

SOURCE Proper Good Inc.